Studies on murine melanona and human breast carcinoma suggest that circulating lymphocytes cannot properly interact with endothelial cells of neovessels expressing diminished levels of CD54, CD106, CD62E and some other CAMs (Dirkx et al, 2003; Bouma-ter Steege et al, 2004). This evidence concerns the gene VCAM1 and breast carcinoma.